BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34564768)

  • 21. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2.
    Chen Y; Li S; Wei Y; Xu Z; Wu X
    Bosn J Basic Med Sci; 2021 Oct; 21(5):555-568. PubMed ID: 33714261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
    Li X; He J; Ren X; Zhao H; Zhao H
    Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma.
    He W; Zhu X; Tang X; Xiang X; Yu J; Sun H
    Anticancer Drugs; 2022 Jan; 33(1):e336-e348. PubMed ID: 34419960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircRNA_0040705 promotes the progression of hepatocellular carcinoma.
    Li Y; Ji M; Huang X; Yang F; Yang Z; Shen L
    IUBMB Life; 2022 May; 74(5):408-418. PubMed ID: 35080329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells.
    Zhao M; Dong G; Meng Q; Lin S; Li X
    J Cell Biochem; 2020 Nov; 121(11):4440-4449. PubMed ID: 32037619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. circRNA 001306 enhances hepatocellular carcinoma growth by up-regulating CDK16 expression via sponging miR-584-5p.
    Liu Q; Wang C; Jiang Z; Li S; Li F; Tan HB; Yue SY
    J Cell Mol Med; 2020 Dec; 24(24):14306-14315. PubMed ID: 33135290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
    Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
    J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 33. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma.
    Zheng H; Bi FR; Yang Y; Hong YG; Ni JS; Ma L; Liu MH; Hao LQ; Zhou WP; Song LH; Yan HL
    Horm Cancer; 2019 Dec; 10(4-6):177-189. PubMed ID: 31713780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p.
    Lu H; Gao L; Lv J
    Ann Hepatol; 2022; 27(1):100551. PubMed ID: 34606982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p.
    Yang W; Ju HY; Tian XF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2347-2357. PubMed ID: 32196586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27.
    Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X
    Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis.
    Luo Z; Yin Y; Tan X; Liu K; Chao Z; Xia H
    Leuk Res; 2022 Feb; 113():106774. PubMed ID: 35030455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis.
    Li Z; Liu Y; Yan J; Zeng Q; Hu Y; Wang H; Li H; Li J; Yu Z
    Aging (Albany NY); 2020 Feb; 12(3):2485-2497. PubMed ID: 32048611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.